NCT01771627View on ClinicalTrials.gov

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 22, 2012

Primary Completion Date

September 28, 2014

Study Completion Date

August 28, 2015

Conditions
Tobacco Use Disorder
Interventions
DRUG

varenicline

Given PO

DRUG

nicotine patch

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT01771627 - Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers | Biotech Hunter | Biotech Hunter